News | Clinical Decision Support | November 17, 2017

HealthMyne Highlights Value of Quantitative Data in Oncology Reads at RSNA 2017

HealthMyne Platform provides consistent, automated measurements and streamlines reading and reporting workflows

HealthMyne Highlights Value of Quantitative Data in Oncology Reads at RSNA 2017

November 17, 2017 — At the 2017 Radiological Society of North America (RSNA) conference, HealthMyne will demonstrate the value of including quantitative data on every oncology read with its HealthMyne Platform.

Even if a patient and their doctor have an idea that something is wrong, the story only begins when a radiologist declares that an abnormality seen on an image is cancer. The information contained in the initial and follow-up reports is used to determine the patient’s progress and therefore needs to be as comprehensive, precise and consistent as possible.

In the HealthMyne Platform, a simple mouse gesture, similar to pulling a measurement, provides radiologists with consistent long and short values that flow to the radiology report in a structured format so there is no need to dictate numbers. Follow-up cases are simplified by automatically opening and registering prior image sets. All previously identified lesions are also propagated to the current images with long and short measurements ascertained and awaiting approval.  

Beyond the report, the quantitative measurements in the HealthMyne Platform are utilized in a variety of ways to increase radiology and the multidisciplinary care team’s value across the enterprise, including: streamlined tumor board preparation and management of these sessions; efficient management of the complex therapy response for clinical trials process; and real-time Incidental Findings documentation, follow-up, scheduling and tracking.

For more information: www.healthmyne.com

Related Content

With the growing adoption of #data #analytics in #healthcare, we are seeing more clearly that there are two sides of data
Feature | Artificial Intelligence | May 05, 2021 | By Sundararajan Mani
With the growing adoption of...
The emergence of #therapeutic #radiopharmaceuticals and its adoption in #cancer care provide one more weapon in combating cancer

Getty Images

Feature | Radiation Oncology | May 04, 2021 | By Vinay Shivaprasad
The term nuclear medicine is associated with the diag
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | May 03, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
Change Healthcare unveiled InterQual 2021, the latest edition of the company’s flagship clinical decision support solution.
News | Clinical Decision Support | April 22, 2021
April 22, 2021 — Change Healthcare unveiled...
Elsevier’s STATdx, a leading radiology diagnostic decision support solution, now includes select Merit-Based Incentive Payment System (MIPS) Measures validated by MDinteractive
News | Clinical Decision Support | April 02, 2021
April 2, 2021 — Elsevier, a global leader in research publishing and information analytics, announced a partnership w
#emphysema #marijuana 2021 ARRS Virtual Annual Meeting research reveals increased rates of emphysema in marijuana smokers, compared to both non-smokers and tobacco-only smokers, as well as greater rates of paraseptal emphysema

Getty Images

News | Lung Imaging | April 02, 2021
April 2, 2021 — A Scientific E-Poster to be presented at the 2021...